GSK and Sierra13 Apr 2022 09:38
When GSK evaluated Sierra for buy out they did not just look at the leading asset ... the whole pipeline would have been thoroughly scrutinised by a team of experts ... what is clear is they found value in the whole pipeline including our 737 ... what is clear is that they will not hesitate to get 737 out for trials and they have the financial resources to do so ... something Sierra could not ... interesting times ahead ... keep you hand on your ha'penny ... LH&K Mafuta